I sat down with @Clive Cookson of the Financial Times to discuss the potential of #GenomicSequencing to accelerate the diagnosis of infectious diseases and improve global surveillance of emerging pathogens. Read the full piece here. 👉on.ft.com/4efo37u 🔗 #Genomics #PacBio

🚨 Huge thanks to Clive Cookson for shedding light on how inadequate #diagnostics are increasing the risk of another pandemic and for speaking with Emmanuel Agogo about the findings of our new readiness index. Check out the article in Financial Times: ft.com/content/3860ad…

On Labiotech.eu podcast, Lili Milani and I discussed the collaboration between PacBio and the Estonian National Biobank, which aims to implement personalised health at scale in Estonia.   Listen to the full podcast, here. 👉bit.ly/3MSFqiX🔗   #Genomics

In Pharmafocus’ October issue, I discuss the diversity deficit in #genomics research and why more diverse reference genomes are key to address health inequalities and ensure that all populations benefit equally from medical advances. 🧬 Read more, here. 👉bit.ly/401i6Hv

In European Biopharmaceutical Review Autumn issue, I discuss how long-read sequencing is transforming five areas of scientific research by helping scientists uncover the complex, unique regions of the genome. 🧬   Read the full article, here. 👉bit.ly/3UkU1aX (pp. 79-82)   #Genomics #PacBio

NEW: Learn how the new SPRQ chemistry for #Revio is improving long-read #sequencing performance and affordability like never before: bit.ly/3Y0Ds6Z #PacBio #ASHG24

With Vega now you can more easily get HiFi in your own lab

In Inside Ecology, I discuss the role of #GenomicSequencing in tackling #biodiversity loss. 🧬 @Darwintreelife is one example of how the UK is harnessing genomic insights to understand species’ health and inform #conservation efforts. 🌍 Read more, here. 👉bit.ly/3CBT48n

In @Laboratorynews, I discuss the role of biobanks in revolutionising precision medicine. 🧬   I explain how the Estonian Biobank is using genomic insights to better understand the factors influencing public health and disease.   Read more, here 👉bit.ly/3ON6xNy   #Biobanks

In @DDDMag, I discuss how advances in long-read sequencing, increasing biobank participation, and pharmacogenomics will transform the diagnosis and treatment of diseases in 2025. 🧬 Read the full Q&A, here. 👉bit.ly/49I6FY7 #Biobanks #PrecisionMedicine

Our new Nature Genetics paper on human segmental duplications (SDs) provides a pangenome perspective of SDs, new potential protein-coding genes, and greater complexity in human variation with implications for disease and evolution. rdcu.be/d5AD9

In @Manchempharma, I discuss the future of #pharmacogenomics. This year will see large-scale PGx research integrate health records, drug response and genetic data at the population level to drive advances in #PrecisionMedicine.🧬 Read more here. 👉bit.ly/3DK34No

Today in Financial Times, I discuss the importance of ramping up biosurvelliance of animal microbiomes to reduce the risk of zoonotic pathogens spilling over into human populations. Read my response to @Michaelpeeljourno’s article here. 👉bit.ly/40CbZsY 🔗 #Genomics #PacBio

To celebrate #RareDiseaseDay2025, I spoke to @Labiotech.EU about long-read sequencing’s vital role in progressing rare disease research and improving the diagnostic pathway. 🧬 Read the full article here.👉 bit.ly/3D9O9fw #Genomics

In Drug Discovery World, I share my prediction for rare disease research in 2025. With advances in long-read sequencing, researchers can unlock the ‘dark regions’ of the genome and identify the genetic underpinnings of rare diseases.   Read more here.👉bit.ly/3QXV6U3 #Genomics

In @Medicine_maker, I explore how advances in #longread sequencing are helping decode the dark regions of the genome.🧬 The latest generation of long-reads are accelerating research into pharmacogenomics, rare diseases, and cancer. Read more here: 👉 bit.ly/3XL8L4R

In MoneyWeek, I discuss how Estonia’s National Biobank is turning genetic data into a powerful tool for personalised medicine. From disease prediction to tailored treatments, biobanks are reshaping healthcare as we know it. Read more here.👉 bit.ly/42Izi4k #Genomics

In The Pathologist, I discuss how genomic sequencing of zoonotic pathogens is key to preventing future pandemics.   Discover how long-read sequencing is transforming biosurveillance and understanding of zoonotic threats: bit.ly/3GMPp9W   #Genomics #PandemicPreparedness

Is it just me that is a little disappointed that the UK government’s strategy docs can’t even get the number of bases in the double helix correct? Is this a sign of what happens when you rely too much on AI? #Genomics

Today with AZoLifeSciences, I explore the UK’s newborn sequencing programme and why long-read sequencing could be a game-changer in this evolving landscape. Read more: tinyurl.com/b5w957w2